Search stocks

Find any stock by ticker or company name

Get all premium features to the best stock analysis tool

Finranks

Company

About us

Contact us

[email protected]

Follow us

Instagram
Telegram
LinkedIn

All rights reserved.

Privacy Policy Terms of Conditions

Home
Watchlist
Markets
Calendar
Screener
News
About

PLSE - Pulse Biosciences, Inc. Financial... | Finranks

Home

/

PLSE

P

Pulse Biosciences, Inc. (PLSE)

NCM – Real Time Price. Currency in USD

44.38

-0.03 (-0.06%)

Market open: Aug 12, 2026, 10:06 AM EDT

44.34

-0.06 (-0.14%)

Previous after-hours: Aug 11, 2026, 7:52 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Total Assets

Total Liabilities

Stockholders Equity

Total Debt

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

350K

0

0

700K

Cost of goods sold

-2M

-1M

-1M

-13M

Gross Profit

-1M

-1M

-1M

-13M

Operating expenses (excl. COGS)

-76M

-53M

-42M

-45M

Operating Income

-77M

-54M

-44M

-58M

Non-operating income, total

4M

776K

1M

-448K

Pretax income

-73M

-54M

-42M

-59M

Equity in earnings

0

0

0

0

Taxes

0

0

0

0

Non-controlling/minority interest

0

0

0

0

After tax other income/expense

0

0

0

0

Net income before discontinued operations

-73M

-54M

-42M

-59M

Discontinued operations

0

0

0

0

Net income

-73M

-54M

-42M

-59M

Dilution adjustment

0

0

0

0

Preferred dividends

0

0

0

0

Name

2025

2024

2023

2022

Total assets

96M-28.3%

134M+120.5%

61M-24.6%

81M

Total current assets

83M

119M

45M

62M

Total non-current assets

13M

15M

15M

18M

Total liabilities

15M-19.5%

19M+16.7%

16M-80.2%

83M

Total current liabilities

8M

10M

7M

6M

Total non-current liabilities

8M

9M

10M

77M

Total equity

81M

115M

44M

-2M

Total liabilities & shareholders' equities

96M

134M

61M

81M

Total debt

8M-15.4%

9M-2.7%

9M-88.0%

76M

Name

2025

2024

2023

2022

Cash from operating activities

-54M

-36M

-33M

-47M

Cash from investing activities

-335K

-125K

-121K

-401K

Cash from financing activities

17M

110M

16M

80M

Free cash flow

-54M-49.3%

-36M-10.0%

-33M+30.1%

-47M